-
公开(公告)号:EP2958591A2
公开(公告)日:2015-12-30
申请号:EP14754905.9
申请日:2014-02-12
IPC分类号: A61K39/395
CPC分类号: A61K31/506 , A61K31/337 , A61K31/517 , A61K31/7088 , A61K45/06 , A61K47/6907 , C12N15/1138 , C12N2310/14 , G01N33/57484 , G01N2500/10 , G01N2800/52 , A61K2300/00
摘要: The compositions and methods described herein relate to the treatment of cancer, e.g. by reducing the regression of cancer cells from regressing into cancer stem cell-like phenotypes and/or reducing the development of drug-resistant cancer cells. In some embodiments, the compositions and methods relate to inhibitors of PI3K pathway kinases and Src family kinases.
-
2.
公开(公告)号:EP2861256A1
公开(公告)日:2015-04-22
申请号:EP13805073.7
申请日:2013-06-14
IPC分类号: A61K47/28 , A61K45/08 , A61K31/015 , A61K31/337 , A61K31/355 , A61K31/519 , A61P35/00
CPC分类号: A61K47/55 , A61K45/06 , A61K47/554
摘要: Described herein are compositions and methods relating to chemotherapeutic agent conjugates and the treatment of cancer.
-